Boston Partners Has $127.78 Million Stock Position in Olin Co. (NYSE:OLN)

Boston Partners trimmed its position in Olin Co. (NYSE:OLN - Free Report) by 11.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,790,241 shares of the specialty chemicals company's stock after selling 513,673 shares during the quarter. Boston Partners owned approximately 3.25% of Olin worth $127,777,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also made changes to their positions in OLN. Empowered Funds LLC increased its holdings in shares of Olin by 126.9% in the 3rd quarter. Empowered Funds LLC now owns 20,498 shares of the specialty chemicals company's stock valued at $983,000 after acquiring an additional 11,466 shares during the last quarter. Segall Bryant & Hamill LLC bought a new stake in shares of Olin in the 3rd quarter valued at approximately $916,000. Commerce Bank increased its holdings in shares of Olin by 48.0% in the 3rd quarter. Commerce Bank now owns 18,069 shares of the specialty chemicals company's stock valued at $867,000 after acquiring an additional 5,863 shares during the last quarter. Pzena Investment Management LLC increased its holdings in shares of Olin by 24.8% in the 3rd quarter. Pzena Investment Management LLC now owns 3,452,708 shares of the specialty chemicals company's stock valued at $165,661,000 after acquiring an additional 685,710 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its stake in Olin by 2.9% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,295,699 shares of the specialty chemicals company's stock worth $62,168,000 after buying an additional 37,043 shares during the last quarter. 88.67% of the stock is currently owned by institutional investors.

Remove Ads

Insider Activity

In related news, CEO Kenneth Todd Lane bought 7,250 shares of Olin stock in a transaction dated Tuesday, February 4th. The stock was acquired at an average cost of $28.06 per share, with a total value of $203,435.00. Following the completion of the acquisition, the chief executive officer now directly owns 7,250 shares in the company, valued at approximately $203,435. This trade represents a ∞ increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 1.60% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the company. Piper Sandler downgraded Olin from an "overweight" rating to a "neutral" rating and lowered their price objective for the stock from $41.00 to $33.00 in a research note on Thursday, February 13th. UBS Group set a $28.00 price objective on Olin in a research note on Thursday, February 27th. KeyCorp lowered their price objective on Olin from $50.00 to $40.00 and set an "overweight" rating for the company in a research note on Monday, February 3rd. Barclays restated an "equal weight" rating on shares of Olin in a research note on Monday, February 3rd. Finally, Morgan Stanley lowered their price objective on Olin from $31.00 to $28.00 and set an "underweight" rating for the company in a research note on Tuesday, February 4th. One research analyst has rated the stock with a sell rating, eleven have given a hold rating and four have issued a buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $38.38.

Olin Price Performance

Shares of Olin stock traded up $0.10 during trading on Friday, hitting $24.98. The stock had a trading volume of 5,361,542 shares, compared to its average volume of 1,408,061. The company has a debt-to-equity ratio of 1.32, a current ratio of 1.27 and a quick ratio of 0.77. The firm has a market cap of $2.88 billion, a P/E ratio of 27.75 and a beta of 1.61. The business has a fifty day moving average of $28.14 and a two-hundred day moving average of $36.71. Olin Co. has a fifty-two week low of $22.98 and a fifty-two week high of $60.60.

Olin (NYSE:OLN - Get Free Report) last announced its quarterly earnings data on Thursday, January 30th. The specialty chemicals company reported $0.09 earnings per share for the quarter, beating the consensus estimate of ($0.01) by $0.10. Olin had a return on equity of 5.10% and a net margin of 1.66%. On average, sell-side analysts expect that Olin Co. will post 1.38 earnings per share for the current fiscal year.

Olin announced that its Board of Directors has approved a stock repurchase plan on Thursday, December 12th that authorizes the company to buyback $2.00 billion in shares. This buyback authorization authorizes the specialty chemicals company to repurchase up to 45% of its shares through open market purchases. Shares buyback plans are usually an indication that the company's leadership believes its stock is undervalued.

Olin Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Thursday, March 6th were issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 3.20%. The ex-dividend date of this dividend was Thursday, March 6th. Olin's dividend payout ratio is 88.89%.

Olin Company Profile

Olin Corporation manufactures and distributes chemical products in the United States, Europe, Asia Pacific, Latin America, and Canada. It operates through three segments: Chlor Alkali Products and Vinyls; Epoxy; and Winchester. The Chlor Alkali Products and Vinyls segment offers chlorine and caustic soda, ethylene dichloride and vinyl chloride monomers, methyl chloride, methylene chloride, chloroform, carbon tetrachloride, perchloroethylene, hydrochloric acid, hydrogen, bleach products, potassium hydroxide, and chlorinated organics intermediates and solvents.